Skip to main content
IPGP
NASDAQ Manufacturing

IPG Q3 Revenue Up 15% to $287.5M; Net Income Doubles to $20.3M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Semiconductor Stocks · Technology
Sentiment info
Positive
Importance info
7
Price
$74.65
Mkt Cap
$3.165B
52W Low
$68.27
52W High
$155.82
52W Position info
9.3% above low
Off High info
52% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

IPGP is trading near its 52-week low of $68.27 (9.3% above the low).

Summary

IPG posted Q3 revenue of $287.5M (+14.6%) and net income of $20.3M ($0.47 diluted), helped by tariff refunds. The 10-Q also details a pending €300M Lumibird Medical acquisition and a ~$25M Q4 property impairment.


Key Events · Earnings and Guidance · IPGP

  • Q3 Revenue Grows 14.6%

    Net sales rose to $287.5M from $250.8M a year ago, with Industrial Solutions up 11.6% and Advanced Solutions up 32.8%.

  • Net Income More Than Doubles

    Net income reached $20.3M ($0.47 diluted) versus $7.5M ($0.18) a year ago; gross margin expanded to 40.7% from 39.5%.

  • Tariff Refunds Flatter Margins

    $5.8M of IEEPA tariff refunds added roughly 170 basis points to Q3 gross margin — a one-time benefit, not recurring operating improvement.

  • Lumibird Deal to Draw Down Cash

    The €300M (~$340.3M) cash acquisition of Lumibird Medical is expected to close in Q4 2026, plus up to €50M (~$56.7M) in earnouts, against $710.7M of cash.


Analysis · IPGP · Manufacturing

IPG's third quarter showed real operating improvement: revenue rose 14.6% to $287.5M and net income more than doubled to $20.3M ($0.47 diluted), with gross margin expanding to 40.7% from 39.5%. Part of that margin gain is one-time help — $5.8M of IEEPA tariff refunds added roughly 170 basis points — so the underlying improvement is smaller than the headline. The bigger story for the balance sheet is what comes next: the €300M (~$340.3M) cash purchase of Lumibird Medical is expected to close in Q4 2026, and the company also flagged an estimated ~$25M pre-tax impairment on properties approved for sale on October 30, 2026. Cash of $710.7M is ample to fund the deal, but it will meaningfully draw down near-term liquidity.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, IPGP was trading at $74.65 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $3.2B. The 52-week trading range was $68.27 to $155.82. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IPGP - Latest Insights

IPGP
Nov 03, 2026, 8:12 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $72.91
Real-time Price: $65.86 info
Change: -$7.05 (-10%) info
Market Cap: $2.715B info
IPGP
Nov 03, 2026, 8:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $72.91
Real-time Price: $65.86 info
Change: -$7.05 (-10%) info
Market Cap: $2.715B info
IPGP
Sep 08, 2026, 4:39 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $79.56
Real-time Price: $65.86 info
Change: -$13.70 (-17%) info
Market Cap: $2.715B info
IPGP
Aug 04, 2026, 4:22 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $94.07
Real-time Price: $65.86 info
Change: -$28.21 (-30%) info
Market Cap: $2.715B info
IPGP
Aug 04, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $93.00
Real-time Price: $65.86 info
Change: -$27.14 (-29%) info
Market Cap: $2.715B info